| Cell Lines From High-Risk Breast Tissue (NCT00032201) | National Cancer Institute (NCI) | 2002-03-06 |
| Thalidomide With or Without Fludarabine in Treating Patients With Hematologic Cancer (NCT00009984) | National Cancer Institute (NCI) | 2002-03-01 |
| Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children (NCT00032669) | National Cancer Institute (NCI) | 2002-03-01 |
| Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer (NCT00039091) | National Cancer Institute (NCI) | 2002-03-01 |
| CC-5013 in Treating Patients With Recurrent Glioma (NCT00036894) | National Cancer Institute (NCI) | 2002-03-01 |
| Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C (NCT00040729) | National Cancer Institute (NCI) | 2002-03-01 |
| Paclitaxel and Bryostatin 1 in Treating Patients With Advanced Pancreatic Cancer (NCT00031694) | National Cancer Institute (NCI) | 2002-03-01 |
| Genetic Analysis of Brain Tumors (NCT00031538) | National Cancer Institute (NCI) | 2002-03-01 |
| Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer (NCT00033462) | National Cancer Institute (NCI) | 2002-03-01 |
| Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases (NCT00033254) | National Cancer Institute (NCI) | 2002-03-01 |
| The New England Bladder Cancer Study (NCT00342875) | National Cancer Institute (NCI) | 2002-03-01 |
| UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors (NCT00036777) | National Cancer Institute (NCI) | 2002-03-01 |
| Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme (NCT00052208) | National Cancer Institute (NCI) | 2002-03-01 |
| Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix (NCT00031993) | National Cancer Institute (NCI) | 2002-03-01 |
| BMS-247550 in Treating Patients With Stage IV Melanoma (NCT00036764) | National Cancer Institute (NCI) | 2002-02-01 |
| Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer (NCT00028834) | National Cancer Institute (NCI) | 2002-02-01 |
| KRN5500 in Treating Patients With Solid Tumors (NCT00017238) | National Cancer Institute (NCI) | 2002-02-01 |
| BMS 247550 to Treat Kidney Cancer (NCT00030992) | National Cancer Institute (NCI) | 2002-02-01 |
| Trastuzumab and Gefitinib in Treating Patients With Metastatic Breast Cancer (NCT00024154) | National Cancer Institute (NCI) | 2002-02-01 |
| CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer (NCT00028028) | National Cancer Institute (NCI) | 2002-02-01 |
| Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer (NCT00033358) | National Cancer Institute (NCI) | 2002-02-01 |
| Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver (NCT00026234) | National Cancer Institute (NCI) | 2002-02-01 |
| Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00033449) | National Cancer Institute (NCI) | 2002-02-01 |
| A Case-Control Study of Testicular Germ Cell Tumors Among U.S. Military Servicemen (NCT00341588) | National Cancer Institute (NCI) | 2002-01-18 |
| Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica (NCT00339807) | National Cancer Institute (NCI) | 2002-01-17 |
| Mafosfamide in Treating Patients With Progressive or Refractory Meningeal Tumors (NCT00031928) | National Cancer Institute (NCI) | 2002-01-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00028821) | National Cancer Institute (NCI) | 2002-01-01 |
| Karenitecin in Treating Patients With Recurrent Malignant Glioma (NCT00014521) | National Cancer Institute (NCI) | 2002-01-01 |
| BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer (NCT00057850) | National Cancer Institute (NCI) | 2002-01-01 |
| Erlotinib in Treating Patients With Recurrent or Metastatic Colorectal Cancer (NCT00032110) | National Cancer Institute (NCI) | 2002-01-01 |
| Bortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00027898) | National Cancer Institute (NCI) | 2002-01-01 |
| Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer (NCT00032188) | National Cancer Institute (NCI) | 2002-01-01 |
| Vaccine Therapy and Monoclonal Antibody Therapy in Treating Patients With Stage IV Melanoma (NCT00032045) | National Cancer Institute (NCI) | 2002-01-01 |
| Erlotinib in Treating Patients With Locally Advanced and/or Metastatic Endometrial Cancer (NCT00030485) | National Cancer Institute (NCI) | 2002-01-01 |
| Celecoxib With or Without Eflornithine in Preventing Colorectal Cancer in Patients With Familial Adenomatous Polyposis (NCT00033371) | National Cancer Institute (NCI) | 2001-12-13 |
| Collection of Blood and Urine From Patients Undergoing Radiation Therapy (NCT00027326) | National Cancer Institute (NCI) | 2001-12-02 |
| Vaccine Therapy in Treating Patients With Metastatic Solid Tumors (NCT00030693) | National Cancer Institute (NCI) | 2001-12-01 |
| Decitabine in Treating Patients With Advanced Solid Tumors (NCT00030615) | National Cancer Institute (NCI) | 2001-12-01 |
| R(+)XK469 in Treating Patients With Advanced Neuroblastoma (NCT00028522) | National Cancer Institute (NCI) | 2001-12-01 |
| PS-341 and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00028587) | National Cancer Institute (NCI) | 2001-12-01 |
| Iododoxorubicin in Treating Patients With Primary Systemic Amyloidosis (NCT00030381) | National Cancer Institute (NCI) | 2001-12-01 |
| 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) (NCT00031681) | National Cancer Institute (NCI) | 2001-12-01 |
| APC8015 and Bevacizumab in Treating Patients With Prostate Cancer (NCT00027599) | National Cancer Institute (NCI) | 2001-12-01 |
| Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00029003) | National Cancer Institute (NCI) | 2001-12-01 |
| Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction (NCT00030498) | National Cancer Institute (NCI) | 2001-12-01 |
| Cancer in Inherited Bone Marrow Failure Syndromes (NCT00027274) | National Cancer Institute (NCI) | 2001-11-28 |
| Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States (NCT00340457) | National Cancer Institute (NCI) | 2001-11-16 |
| Fungicide Exposure Assessment Among Apple and Peach Farmers in the Argicultural Health Study (NCT00342394) | National Cancer Institute (NCI) | 2001-11-14 |
| Genome Expression in Lymphoma, Leukemia and Multiple Myeloma (NCT00339963) | National Cancer Institute (NCI) | 2001-11-09 |
| Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews (NCT00341900) | National Cancer Institute (NCI) | 2001-11-09 |
| The Incidence of Breast and Other Cancers Among Female Flight Attendants (NCT00342407) | National Cancer Institute (NCI) | 2001-11-06 |
| Calibration of Urine pH Strips for NCI Case-Control Studies on Bladder Cancer and Comparison of DNA Yields From Buccal Cells Collected Through Two Different Methods (NCT00339443) | National Cancer Institute (NCI) | 2001-11-06 |
| Family Study of Melanoma in Italy (NCT00339222) | National Cancer Institute (NCI) | 2001-11-05 |
| Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00023712) | National Cancer Institute (NCI) | 2001-11-05 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer (NCT00028496) | National Cancer Institute (NCI) | 2001-11-01 |
| Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors (NCT00028535) | National Cancer Institute (NCI) | 2001-11-01 |
| Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer (NCT00026104) | National Cancer Institute (NCI) | 2001-11-01 |
| Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma (NCT00026221) | National Cancer Institute (NCI) | 2001-11-01 |
| ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer (NCT00026364) | National Cancer Institute (NCI) | 2001-11-01 |
| Bortezomib in Treating Children With Advanced Solid Tumors (NCT00021216) | National Cancer Institute (NCI) | 2001-11-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00030537) | National Cancer Institute (NCI) | 2001-11-01 |
| Molecular Epidemiology of Cutaneous Malignant Melanoma (NCT00341991) | National Cancer Institute (NCI) | 2001-11-01 |
| Comparison of Chemotherapy Regimens in Treating Children With Relapsed or Progressive Rhabdomyosarcoma (NCT00025363) | National Cancer Institute (NCI) | 2001-11-01 |
| Bryostatin 1 Plus Vincristine in Treating Patients With Recurrent or Refractory HIV-Related Lymphoma (NCT00022555) | National Cancer Institute (NCI) | 2001-11-01 |
| Bortezomib and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors (NCT00030368) | National Cancer Institute (NCI) | 2001-11-01 |
| Case-Control Study of Pesticides and Childhood Leukemia (NCT00342888) | National Cancer Institute (NCI) | 2001-10-30 |
| Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma (NCT00026312) | National Cancer Institute (NCI) | 2001-10-26 |
| Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma (NCT00026143) | National Cancer Institute (NCI) | 2001-10-01 |
| Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer (NCT00020631) | National Cancer Institute (NCI) | 2001-10-01 |
| Rituximab and Interleukin-12 in Treating Patients With B-Cell Non-Hodgkin's Lymphoma (NCT00026182) | National Cancer Institute (NCI) | 2001-10-01 |
| B-Lymphocyte Stimulator (BLyS) To Treat Selective IgA Deficiency (NCT00024934) | National Cancer Institute (NCI) | 2001-10-01 |
| Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia (NCT00027872) | National Cancer Institute (NCI) | 2001-10-01 |
| EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer (NCT00028782) | National Cancer Institute (NCI) | 2001-10-01 |
| BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors (NCT00028561) | National Cancer Institute (NCI) | 2001-10-01 |
| Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Malignant Mesothelioma (NCT00027703) | National Cancer Institute (NCI) | 2001-10-01 |
| Tenofovir Disoproxil Fumarate to Treat Pediatric HIV (NCT00024986) | National Cancer Institute (NCI) | 2001-10-01 |
| Biological Specimen Collection for Laboratory Methods Development and Training Purposes (NCT00025831) | National Cancer Institute (NCI) | 2001-10-01 |
| Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer (NCT00023933) | National Cancer Institute (NCI) | 2001-10-01 |
| Eligibility Screening for a NCI Pediatric Oncology Branch Research Study (NCT00026780) | National Cancer Institute (NCI) | 2001-09-24 |
| Thalidomide in Treating Patients With Recurrent or Persistent Cancer of the Uterus (NCT00025220) | National Cancer Institute (NCI) | 2001-09-01 |
| Gefitinib in Treating Patients With Malignant Mesothelioma (NCT00025207) | National Cancer Institute (NCI) | 2001-09-01 |
| Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed During Surgery (NCT00025246) | National Cancer Institute (NCI) | 2001-09-01 |
| Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer (NCT00026091) | National Cancer Institute (NCI) | 2001-09-01 |
| Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated (NCT00025337) | National Cancer Institute (NCI) | 2001-09-01 |
| Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer (NCT00025467) | National Cancer Institute (NCI) | 2001-09-01 |
| Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus (NCT00025506) | National Cancer Institute (NCI) | 2001-09-01 |
| 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors (NCT00030095) | National Cancer Institute (NCI) | 2001-09-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Kidney Failure (NCT00026169) | National Cancer Institute (NCI) | 2001-09-01 |
| Combination Antibody Therapy for Relapsed Lymphoma and Chronic Lymphocytic Leukemia (NCT00022971) | National Cancer Institute (NCI) | 2001-08-15 |
| Gene Therapy for Patients With Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial) (NCT00023010) | National Cancer Institute (NCI) | 2001-08-15 |
| Construction and Use of Lung Tumor Microarray for the Analysis of Gene Expression in Lung Cancer (NCT00340847) | National Cancer Institute (NCI) | 2001-08-09 |
| PS-341 in Treating Women With Metastatic Breast Cancer (NCT00025584) | National Cancer Institute (NCI) | 2001-08-01 |
| BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma (NCT00024024) | National Cancer Institute (NCI) | 2001-08-01 |
| BMS-247550 in Treating Patients With Liver or Gallbladder Cancer (NCT00023946) | National Cancer Institute (NCI) | 2001-08-01 |
| Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction (NCT00025415) | National Cancer Institute (NCI) | 2001-08-01 |
| EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer (NCT00896961) | National Cancer Institute (NCI) | 2001-08-01 |
| R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas (NCT00021541) | National Cancer Institute (NCI) | 2001-07-17 |
| Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer (NCT00030082) | National Cancer Institute (NCI) | 2001-07-01 |
| Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT00022581) | National Cancer Institute (NCI) | 2001-07-01 |
| Interleukin-12 in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer (NCT00016289) | National Cancer Institute (NCI) | 2001-07-01 |